Laparoscopy Devices Market Report 2025

The laparoscopy devices market size has grown strongly in recent years. It will grow from $12.75 billion in 2024 to $13.6 billion in 2025 at a compound annual growth rate (CAGR) of 6.6%. The growth in the historic period can be attributed to improved surgeon training programs, enhanced safety and efficacy, shift towards minimally invasive surgery, evolution in energy-based devices, early adoption challenges.

The laparoscopy devices market size is expected to see strong growth in the next few years. It will grow to $18.43 billion in 2029 at a compound annual growth rate (CAGR) of 7.9%. The growth in the forecast period can be attributed to customization and patient-centric approach, market penetration in emerging economies, training and skill enhancement programs, integration of robotic-assisted systems, growth in energy-based devices. Major trends in the forecast period include miniaturization of devices, rise in minimally invasive surgeries, adoption in emerging economies, focus on training and education, integration of robotics.

The rising incidence of chronic diseases is projected to drive the expansion of the laparoscopy devices market in the future. Chronic diseases are characterized as health issues that persist for a year or more, requiring ongoing medical treatment and often limiting daily activities. Examples of such diseases include heart disease, cancer, obesity, and diabetes. Laparoscopy can provide patients suffering from undiagnosed chronic abdominal pain with accurate diagnoses and therapeutic interventions. Additionally, research indicates that these devices facilitate minimally invasive surgical techniques. A report released by the American College of Cardiology in August 2022 highlighted that all four major cardiovascular risk factors in the United States are expected to rise between 2025 and 2060. The most significant increase is anticipated in diabetes, with a 39.3% rise to 55 million individuals, followed by dyslipidemia (27.6% to 126 million), hypertension (25.1% to 162 million), and obesity (18.3% to 126 million). Furthermore, notable increases in cardiovascular disease rates are expected, including a 33.8% rise in stroke cases (up to 15 million) and a 33.4% increase in heart failure (up to 13 million). Ischemic heart disease (up 30.7% to 29 million) and heart attack (up 16.9% to 16 million) will also see significant growth. Consequently, the rising prevalence of chronic diseases is a key factor in the growth of the laparoscopy devices market.

The laparoscopy devices market is also set to grow owing to the increasing prevalence of obesity. Obesity, a condition marked by excessive body fat accumulation and defined by a body mass index (BMI) of 30 or higher, poses significant health risks. Laparoscopy devices are commonly employed in minimally invasive surgical procedures for obese individuals, resulting in reduced postoperative complications and faster recovery. As of March 2022, the World Health Organization reported that over 1 billion people globally, including 650 million adults, 340 million adolescents, and 39 million children, were affected by obesity. This number continues to rise, with an estimated 167 million people experiencing deteriorating health due to being overweight or obese by 2025. Hence, the laparoscopy devices market is propelled by the increasing prevalence of obesity.

Leading companies in the laparoscopy devices market are focused on developing advanced energy systems to improve surgical outcomes and enhance procedural efficiency. These innovative energy devices, which integrate state-of-the-art technology with versatility, are essential for laparoscopic surgeries. For example, in September 2022, Olympus Corporation, a Japanese medical technology firm dedicated to creating solutions for disease detection, prevention, and treatment, introduced the THUNDERBEAT Open Fine Jaw Type X surgical energy devices designed for open surgery. This device combines advanced energy delivery with precise tissue manipulation, facilitating effective dissection and coagulation. Its design enhances surgical efficiency while minimizing thermal spread, making it especially valuable in laparoscopic procedures, where precision and control are critical for achieving successful results.

Prominent companies in the laparoscopy devices market are focusing on the development of advanced visualization systems to boost surgical precision and enhance clinical outcomes. High-definition imaging solutions, particularly those that combine 3D visualization with intuitive features, are essential for laparoscopic procedures. For example, in May 2023, B. Braun, a healthcare company based in Germany, introduced the AESCULAP EinsteinVision 3 FI system. This system improves laparoscopic surgeries through its advanced 3D fluorescence imaging capabilities, enabling real-time visualization of critical structures like blood vessels and bile ducts. Its built-in anti-fog technology ensures a clear view throughout the procedure, while various fluorescence overlay modes offer flexibility in assessing tissue perfusion and anatomy. By facilitating accurate navigation and decision-making during minimally invasive interventions, this system significantly reduces operating times and enhances surgical outcomes.

In June 2023, STERIS plc, an Ireland-based provider specializing in infection prevention, decontamination, and surgical products, completed the acquisition of surgical instrumentation assets from Becton, Dickinson, and Company for $540 million. This acquisition was intended to enhance STERIS's portfolio in surgical solutions, with a particular emphasis on broadening its selection of high-quality surgical instruments to better meet the needs of healthcare providers. Becton, Dickinson, and Company is a US-based company that supplies laparoscopy devices.

Major companies operating in the laparoscopy devices market include B. Braun Melsungen AG, Boston Scientific Corporation, CONMED Corporation, Ethicon Inc., Karl Storz SE & Co. KG, Medtronic PLC, Olympus Corporation, Richard Wolf GmbH, Smith & Nephew PLC, Stryker Corporation, Intuitive Surgical Inc., The Cooper Companies Inc., Microline Surgical Inc., Becton Dickinson and Company, Welfare Medical Ltd., Applied Medical Resources Corporation, Cooper Surgical Inc., Fujifilm Holdings Corporation, Grena Ltd., Henke-Sass Wolf GmbH, LaproSurge Ltd., Maxer Endoscopy GmbH, MedGyn Products Inc., EndoOptiks Inc., EndoChoice Inc., Endo-Technik W. Griesat GmbH, Endo-Flex GmbH, Endo-Therapeutics Inc., Smiths Group plc, LiNA Medical ApS.

North America was the largest region in the laparoscopy devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global laparoscopy devices market report during the forecast period. The regions covered in the laparoscopy devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the laparoscopy devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Laparoscopy devices are comprised of rigid endoscopes equipped with telescopic rod lens systems, typically connected to single-chip or three-chip video cameras. These devices enable surgeons to access the abdominal and pelvic regions without the need for significant skin incisions.

The primary types of laparoscopy devices include laparoscopes, energy devices, insufflators, robot-assisted surgery systems, suction or irrigation systems, closure devices, hand instruments, access devices, accessories, and others. Laparoscopes, for instance, are small, tube-shaped medical devices featuring a light, a lens, and an instrument for tissue removal. They find applications in various surgical procedures, including general surgery, bariatric surgery, and gynecological surgery, and are utilized by diverse end users such as hospitals, clinics, and others.

The laparoscopy devices market research report is one of a series of new reports that provides laparoscopy devices market statistics, including laparoscopy devices industry global market size, regional shares, competitors with a laparoscopy devices market share, detailed laparoscopy devices market segments, market trends and opportunities, and any further data you may need to thrive in the laparoscopy devices industry. This laparoscopy devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The laparoscopy devices market consists of sales of laparoscopic scissors, graspers, needle handles, dissectors, and retractors. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.